Golden China International Pharmaceutical & Medical Venture Capital (Golden China Fund) is a private equity firm based in China. The firm was formed from the cooperation agreement signed between Tianjing Tasly Group and Tianjin Binhai New Area Venture Capital Government Guiding Fund. The GP team was first recruited by Tasly Group in 2007. Golden China Fund focuses mainly on growth opportunities within China and targets the medical and pharmaceuticals sectors.
Growth
2 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.